Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Tysabri may be option for kids with MS
The glutathione S-transferase T1 deletion is associated with susceptibility to multiple sclerosis.
Blocking KCa3.1 Channels Increases Tumor Cell Killing by a Subpopulation of Human Natural Killer Lymphocytes.
[Multiple sclerosis within the Spanish context].
Natural interferon-beta in chronic progressive multiple sclerosis: results after 2 years of treatment and 2 years of follow up.
Central motor conduction as a measure of disease progression in early multiple sclerosis.
Longitudinal T cell-derived IFN-γ/IL-17 balances do not correlate with the disease course in two mouse models of experimental autoimmune encephalomyelitis.
Treatment options for patients with multiple sclerosis who have a suboptimal response to interferon-β therapy.
[Vitamin d, determinant of bone and extrabone health . Import ance of vitamin d supplementation in milk and dairy products].
Quantitative Phosphoproteomic Analyses of the Inferior Parietal Lobule from Three Different Pathological Stages of Alzheimer's Disease.
Neurostereology protocol for unbiased quantification of neuronal injury and neurodegeneration.
A proposed dosing algorithm for the individualized dosing of human immunoglobulin in chronic inflammatory neuropathies.
Perceived Impact of a Self-Management Program for Fatigue in Multiple Sclerosis: A Qualitative Study.
Alemtuzumab for multiple sclerosis.
A leading role for NADPH oxidase in an in-vitro study of experimental autoimmune encephalomyelitis.
Monocyte chemoattractant protein-1 promoter -2518 polymorphism and susceptibility to vasculitis, rheumatoid arthritis, and multiple sclerosis: A meta-analysis.
The role of cannabinoids and leptin in neurological diseases.
Vitamin D and multiple sclerosis-from epidemiology to prevention.
Humoral Responses to Diverse Autoimmune Disease-Associated Antigens in Multiple Sclerosis.
There is no evidence to support or refute the effectiveness of memory rehabilitation on memory function or functional abilities in people with multiple sclerosis.
Sub-analysis of geographical variations in the 2-year observational COPTIMIZE trial of patients with relapsing-remitting multiple sclerosis converting to glatiramer acetate.
Characteristics of Patients with Relapsing Remitting Multiple Sclerosis Taking once Daily Teriflunomide Tablets in the United States.
Rehabilitation of multiple sclerosis patients in India.
Efficacy and safety of onabotulinumtoxinA therapy are sustained over 4 years of treatment in patients with neurogenic detrusor overactivity: Final results of a long-term extension study.
The interplay between bacillus Calmette-Guérin and Treg cells and its role to prevent or cure inflammatory diseases.
Pages
« first
‹ previous
…
679
680
681
682
683
684
685
686
687
…
next ›
last »